Haemonetics completes tender offer for Global Med

Thu, 03/25/2010 - 4:30am
The Associated Press

Blood collection and processing systems maker Haemonetics Inc. said Thursday it completed the $60 million tender offer for Global Med Technologies Inc.

The company said last month that it would buy the health information technology company for $1.22 per share, and its preferred stock at about $1,694 each.

Haemonetics has tendered 100 percent of the Global Med's preferred stock and 82 percent of outstanding common stock.

The company will provide a subsequent offering period which will expire on March 31, unless extended. It will complete the buyout after the subsequent offering period expires.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.